Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System

— Executive appointments position the company for continued growth and expansion —

Excerpt from the Press Release:

SAN DIEGO–(BUSINESS WIRE)–Truvian Sciences (“Truvian”) today announced four executive appointments that bring expanded industry and commercialization experience to the company as it advances toward submitting for U.S. Food and Drug Administration (FDA) clearance of its automated benchtop blood testing system.

Truvian has appointed Ajay Bansal as Chief Financial Officer, Tyler Jensen as Chief Product Officer, Joe Benson as Vice President of Strategy and Portfolio Management, and Eric Zieger as Vice President of Global Sales. Complementing the executive appointments, Truvian announced existing team members Jay Srinivasan has been named Chief Strategy Officer, and Co-founder Dena Marrinucci has been named Chief Science Officer.

“Truvian is at a pivotal point in our company evolution as we progress towards global regulatory approvals and commercialization of our benchtop blood testing system,” said Jeff Hawkins, President and CEO of Truvian. “The appointments of Ajay, Tyler, Joe and Eric will prove invaluable to Truvian as we accelerate our growth and expansion through the commercialization of our system and make routine testing more convenient and accessible for all.”

Ajay Bansal has served as a Chief Financial Officer at biotechnology companies for nearly 20 years. Most recently, he was Chief Financial Officer and Head of Business Development at Urovant Sciences, which was acquired by Dainippon Sumitomo Pharma in March 2021. Ajay holds a B.Tech. in Mechanical Engineering from the Indian Institute of Technology, New Delhi, an M.S. in Operations Research from Northwestern University and an M.B.A. from the Kellogg Graduate School of Management.

Click the button below to read the entire Press Release:

Continue Reading The Press Release